Source link : https://www.newshealth.biz/health-news/novel-anti-cd38-drug-shows-promise-for-immune-thrombocytopenia/
An investigational anti-CD38 monoclonal antibody (CM313) rapidly increased platelets in immune thrombocytopenia (ITP) patients to levels sufficient for preventing bleeding, a small single-arm Chinese study showed. In the phase I/II trial of 22 ITP patients who had previously received multiple therapies, all but one patient had two or more consecutive platelet counts of at least […]
Author : News Health
Publish date : 2024-06-19 21:00:00
Copyright for syndicated content belongs to the linked Source.
Categories